United States · Venture startup

Who invested in Stingray Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$6.6Mraised across 1 round since 2023, from 1 source

Latest round
Venture, $6.6MMar 2023
Investors
1
See who backed them

The rounds

  1. Mar 2023
    Venture$6.6M

    Source recordedSEC filing: $3.9M sold, first sale Jan 2023

Founders and team

From the SEC filings it signed: 3 on the team.

  • Jonathan P. NorthrupExecutive Officer, Directori
  • Sunil P. SharmaExecutive Officer, Directori
  • Uma P. BhattExecutive Officer, Directori

Everyone who backed them

Newchip AcceleratorAccelerator1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Stingray Therapeutics

Who invested in Stingray Therapeutics?

Stingray Therapeutics's investors include Newchip Accelerator.

How much has Stingray Therapeutics raised?

Stingray Therapeutics has raised $6.6M across 1 round since 2023.

When did Stingray Therapeutics last raise?

Stingray Therapeutics's most recent round was a Venture of $6.6M in Mar 2023.

What was Stingray Therapeutics's biggest round?

Its most recent round, $6.6M in Mar 2023, is also its largest on record.

Who backed Stingray Therapeutics first?

Stingray Therapeutics's first round on record, in Mar 2023, was backed by Newchip Accelerator.

What stage is Stingray Therapeutics at?

Stingray Therapeutics's latest named round is a Venture, in Mar 2023.

Where is Stingray Therapeutics based?

Stingray Therapeutics is based in the United States.

Companies like Stingray Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.